No connection

Search Results

IMCC vs PRFX

IMCC
IM Cannabis Corp.
BEARISH
Price
$0.36
Market Cap
$2.2M
Sector
Healthcare
AI Confidence
95%
PRFX
PRF Technologies Ltd.
BEARISH
Price
$2.73
Market Cap
$2.3M
Sector
Healthcare
AI Confidence
95%

Valuation

P/E Ratio
IMCC
--
PRFX
--
Forward P/E
IMCC
-0.28
PRFX
-0.23
P/B Ratio
IMCC
-0.8
PRFX
0.27
P/S Ratio
IMCC
0.04
PRFX
135.62
EV/EBITDA
IMCC
-3.49
PRFX
0.25

Profitability

Gross Margin
IMCC
17.7%
PRFX
0.0%
Operating Margin
IMCC
-31.42%
PRFX
-16200.0%
Profit Margin
IMCC
-20.68%
PRFX
0.0%
ROE
IMCC
--
PRFX
-90.37%
ROA
IMCC
-10.92%
PRFX
-38.75%

Growth

Revenue Growth
IMCC
17.6%
PRFX
--
Earnings Growth
IMCC
--
PRFX
--

Financial Health

Debt/Equity
IMCC
--
PRFX
0.0
Current Ratio
IMCC
0.67
PRFX
1.78
Quick Ratio
IMCC
0.41
PRFX
1.75

Dividends

Dividend Yield
IMCC
--
PRFX
--
Payout Ratio
IMCC
0.0%
PRFX
0.0%

AI Verdict

IMCC BEARISH

IMCC exhibits severe financial distress, characterized by a Piotroski F-Score of 4/9 and the absence of a Graham Number or Altman Z-Score due to negative equity (Price/Book: -0.80). While the company has shown recent revenue growth of 17.6% and a series of EPS 'beats,' these are marginal improvements on a foundation of deep losses and negative margins. The catastrophic 5-year price decline of 99.9% and a current ratio of 0.67 indicate a high risk of insolvency and a lack of investor confidence.

Strengths
Positive YoY revenue growth of 17.60%
Recent quarterly EPS beats (3 of last 4 quarters)
Extremely low Price/Sales ratio (0.04)
Risks
Negative equity as indicated by Price/Book of -0.80
Severe liquidity risk with a Current Ratio of 0.67 and Quick Ratio of 0.41
Persistent negative operating margins (-31.42%)
PRFX BEARISH

PRFX exhibits severe financial distress, characterized by a Piotroski F-Score of 4/9, which barely places it in the 'stable' category despite catastrophic operating margins of -16,200%. The absence of an Altman Z-Score and Graham Number reflects a lack of positive earnings and stable valuation foundations. With a Price-to-Sales ratio of 135.62 and a 5-year price collapse of 99.7%, the company appears to be a speculative shell with virtually no meaningful revenue generation. While the current ratio of 1.78 provides a temporary liquidity cushion, the fundamental business model is currently non-viable.

Strengths
Zero debt-to-equity ratio
Current ratio of 1.78 indicates short-term liquidity
Recent Q/Q EPS growth showing improvement from deep negatives
Risks
Extreme operating margin of -16,200% indicating massive inefficiency
Absurdly high Price-to-Sales ratio (135.62) suggesting negligible revenue
Total collapse of long-term shareholder value (-99.7% over 5 years)

Compare Another Pair

IMCC vs PRFX: Head-to-Head Comparison

This page compares IM Cannabis Corp. (IMCC) and PRF Technologies Ltd. (PRFX) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile